Placenta and fetal growth restriction

Clinical Obstetrics and Gynecology

Volumn 49, Issue 2, 2006, Pages 236-256

  Salafia, Carolyn M ^a   Charles, Adrian K ^b   Maas, Elizabeth M ^c  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b Princess Margaret Memorial Hospital   (Australia)

^c EarlyPath Clinical and Research Diagnostics   (United States)

Author keywords

Acute inflammation; Birth weight; Chronic inflammation; Fetoplacental weight ratio; Placental growth; Ponderal index; Vascular pathology

Indexed keywords

OXYGEN;

BIRTH WEIGHT; EMBRYOLOGY; FETOMATERNAL TRANSFUSION; FETUS CIRCULATION; FETUS GROWTH; HISTOPATHOLOGY; HUMAN; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; LONG TERM CARE; MATERNAL NUTRITION; MICROSCOPY; NUTRIENT; PATHOLOGY; PLACENTA; PLACENTA CIRCULATION; PLACENTA DEVELOPMENT; PLACENTA FUNCTION; PLACENTA WEIGHT; REVIEW; RISK ASSESSMENT; UMBILICAL CORD; VASCULAR DISEASE;

BIRTH WEIGHT; FETAL GROWTH RETARDATION; FETUS; GESTATIONAL AGE; HUMANS; PLACENTA;

EID: 33748269858     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200606000-00007     Document Type: Review

References (119)

1. Kuh D, Hardy R. A life course approach to women's health. Oxford, New York: Oxford University Press; 2002.
2. Kuh D, Ben-Shlomo Y. A life course approach to chronic disease epidemiology. 2nd ed. Oxford, New York: Oxford University Press; 2004.
3. Catalano PM, Kirwan JP. Maternal factors that determine neonatal size and body fat. Curr Diab Rep. 2001;1:71-77.
4. Thame M, Osmond C, Bennett F, et al. Fetal growth is directly related to maternal anthropometry and placental volume. Eur J Clin Nutr. 2004;58:894-900.
5. Wallace JM, Aitken RP, Milne JS, et al. Nutritionally mediated placental growth restriction in the growing adolescent: consequences for the fetus. Biol Reprod. 2004;71:1055-1062.
6. Clapp JF, III, Schmidt S, Paranjape A, et al. Maternal insulin-like growth factor-I levels (IGF-I) reflect placental mass and neonatal fat mass. Am J Obstet Gynecol. 2004;190:730-736.
7. Laviola L, Perrini S, Belsanti G, et al. Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. Endocrinology. 2005;146:1498-1505.
8. MacLennan NK, James SJ, Melnyk S, et al. Uteroplacental insufficiency alters DNA methylation, one-carbon metabolism, and histone acetylation in IUGR rats. Physiol Genomics. 2004;18:43-50.
9. Lepercq J, Guerre-Millo M, Andre J, et al. Leptin: a potential marker of placental insufficiency. Gynecol Obstet Invest. 2003;55:151-155.
10. Lackman F, Capewell V, Gagnon R, et al. Fetal umbilical cord oxygen values and birth to placental weight ratio in relation to size at birth. Am J Obstet Gynecol. 2001;185:674-682.
11. Benirschke K. Examination of the placenta. Obstet Gynecol. 1961;18:309-333.
12. Benirschke K. Examination of the Placenta, prepared for the Collaborative study on Cerebral Palsy, Mental Retardation and Other Neurological and Sensory Disorders of Infancy and Childhood. Washington DC: U.S. Department of Health, Education and Welfare, Public Health Service; 1961.
13. Moore KL, Persaud TVN. The placenta and fetal membranes. In: The Developing Human: Clinically Oriented Embryology. 5th ed. Philadelphia: Saunders; 1993:114-116.
14. Benirschke K, Kaufmann P. Placenta shape aberrations. In: Pathology of the Human Placenta. 4th ed. New York: Springer; 2000:401-404.
15. Naeye RL. Disorders of the Placenta, Fetus, and Neonate: Diagnosis and Clinical Significance. St. Louis: Mosby Year Book; 1992:132.
16. Benirschke K, Kaufmann P. Nonvillous parts and trohoblast invasion. In: Pathology of the Human Placenta. 4th ed. New York: Springer; 2000:208.
17. Boyd JD, Hamilton WJ. The Human Placenta. Cambridge, England: Heffer; 1970.
18. Craven CM, Zhao L, Ward K. Lateral placental growth occurs by trophoblast cell invasion of decidual veins. Placenta. 2000;21:160-169.
19. Gruenwald P. Lobular architecture of the primate placentas. In: The Placenta and its Maternal Supply Line; Effects of Insufficiency on the Fetus. Lancaster, England: MTP Medical and Technical Pub. Co; 1975:43.
20. Popek EJ. Normal anatomy and histology of the placenta. In: Lewis SH, Perrin EVDK, eds. Pathology of the Placenta. 2nd ed. New York: Churchill Livingstone; 1999:66-67.
21. Raio L, Ghezzi F, Cromi A, et al. The thick heterogeneous (jellylike) placenta: a strong predictor of adverse pregnancy outcome. Prenat Diagn. 2004;24:182-188.
22. Thompson MO, Vines SK, Aquilina J, et al. Are placental lakes of any clinical significance? Placenta. 2002;23:685-690.
23. Nordenvall M, Ullberg U, Laurin J, et al. Placental morphology in relation to umbilical artery blood velocity wave-forms. Eur J Obstet Gynecol Reprod Biol. 1991;40:179-190.
24. Doherty CB, Lewis RM, Sharkey A, et al. Placental composition and surface area but not vascularization are altered by maternal protein restriction in the rat. Placenta. 2003;24:34-38.
25. Lewis RM, Doherty CB, James LA, et al. Effects of maternal iron restriction on placental vascularization in the rat. Placenta. 2001;22:534-539.
26. Reshetnikova OS, Burton GJ, Teleshova OV. Placental histomorphometry and morphometric diffusing capacity of the villous membrane in pregnancies complicated by maternal iron-deficiency anemia. Am J Obstet Gynecol. 1995;173:724-727.
27. Hempstock J, Bao YP, Bar-Issac M, et al. Intralobular differences in antioxidant enzyme expression and activity reflect the pattern of maternal arterial bloodflow within the human placenta. Placenta. 2003;24:517-523.
28. Karimu AL, Burton GJ. Star volume estimates of the intervillous clefts in the human placenta: how changes in umbilical arterial pressure might influence the maternal placental circulation. J Dev Physiol. 1993;19:137-142.
29. Karimu AL, Burton GJ. The effects of maternal vascular pressure on the dimensions of the placental capillaries. Br J Obstet Gynaecol. 1994;101:57-63.
30. Wyatt SM, Kraus FT, Roh CR, et al. The correlation between sampling site and gene expression in the term human placenta. Placenta. 2005;26:372-379.
31. Karimu AL, Burton GJ. Significance of changes in fetal perfusion pressure to factors controlling angiogenesis in the human term placenta. J Reprod Fertil. 1994;102:447-450.
32. Li YS, Haga JH, Chien S. Molecular basis of the effects of shear stress on vascular endothelial cells. J Biomech. 2005;38:1949-1971.
33. Prefumo F, Guven M, Ganapathy R, et al. The longitudinal variation in uterine artery blood flow pattern in relation to birth weight. Obstet Gynecol. 2004;103:764-768.
34. Carbillon L, Uzan M, Largilliere C, et al. Prospective evaluation of uterine artery flow velocity waveforms at 12-14 and 22-24 weeks of gestation in relation to pregnancy outcome and birth weight. Fetal Diagn Ther. 2004;19:381-384.
35. Mayhew TM, Ohadike C, Baker PN, et al. Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. Placenta. 2003;24:219-226.
36. Hafner E, Metzenbauer M, Hofinger D, et al. Placental growth from the first to the second trimester of pregnancy in SGA-foetuses and pre-eclamptic pregnancies compared to normal foetuses. Placenta. 2003;24:336-342.
37. Xiao R, Sorensen TK, Williams MA, et al. Influence of pre-eclampsia on fetal growth. J Matern Fetal Neonatal Med. 2003;13:157-162.
38. Robertson WB, Brosens I, Dixon G. Uteroplacental vascular pathology. Eur J Obstet Gynecol Reprod Biol. 1975;5:47-65.
39. Naeye RL. Pregnancy hypertension, placental evidences of low uteroplacental blood flow, and spontaneous premature delivery. Hum Pathol. 1989;20:441-444.
40. Arias F, Rodriquez L, Rayne SC, et al. Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol. 1993;168:585-591.
41. Salafia CM, Ernst LM, Pezzullo JC, et al. The very low birth weight infant: maternal complications leading to preterm birth, placental lesions, and intrauterine growth. Am J Perinatol. 1995;12:106-110.
42. Friedman SA, de Groot CJ, Taylor RN, et al. Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation. Am J Obstet Gynecol. 1994;170:838-841.
43. Sobrevia L, Mann GE. Dysfunction of the endothelial nitric oxide signalling pathway in diabetes and hyperglycaemia. Exp Physiol. 1997;82:423-452.
44. Gao Z, Zhang X, Zuberi A, et al. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3-L1 adipocytes. Mol Endocrinol. 2004;18:2024-2034.
45. Yano M, Hasegawa G, Ishii M, et al. Short-term exposure of high glucose concentration induces generation of reactive oxygen species in endothelial cells: implication for the oxidative stress associated with postprandial hyperglycemia. Redox Rep. 2004;9:111-116.
46. Salafia CM, Starzyk KA, Lage JM, et al. Lipoprotein(a) deposition in the uteroplacental bed and in basal plate uteroplacental arteries: implications for atherosclerosis-associated processes in normal and complicated pregnancies. Troph Res. 1998;11:377-387.
47. Kupferminc MJ, Rimon E, Ascher-Landsberg J, et al. Perinatal outcome in women with severe pregnancy complications and multiple thrombophilias. J Perinat Med. 2004;32:225-227.
48. von Kries R, Junker R, Oberle D, et al. Foetal growth restriction in children with prothrombotic risk factors. Thromb Haemost. 2001;86:1012-1016.
49. Brosens I, Dixon HG, Robertson WB. Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaecol. 1977;84:656-663.
50. Sheppard BL, Bonnar J. Ultrastructural abnormalities of placental villi in placentae from pregnancies complicated by intrauterine fetal growth retardation: their relationship to decidual spiral arterial lesions. Placenta. 1980;1:145-156.
51. Gerretsen G, Huisjes HJ, Elema JD. Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol. 1981;88:876-881.
52. Sheppard BL, Bonnar J. An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. Br J Obstet Gynaecol. 1981;88:695-705.
53. Hustin J, Foidart JM, Lambotte R. Maternal vascular lesions in preeclampsia and intrauterine growth retardation: light microscopy and immunofluorescence. Placenta. 1983;4 Spec No:489-498.
54. Gerretsen G, Huisjes HJ, Hardonk MJ, et al. Trophoblast alterations in the placental bed in relation to physiological changes in spiral arteries. Br J Obstet Gynaecol. 1983;90:34-39.
55. Brosens I, Renaer M. On the pathogenesis of placental infarcts in pre-eclampsia. J Obstet Gynaecol Br Commonw. 1972;79:794-799.
56. Wigglesworth JS, Singer DB. Textbook of Fetal and Perinatal Pathology. Boston: Blackwell Scientific Publications; St Louis, Mo: Distributors, USA and Canada, Mosby-Year Book; 1991.
57. Mooney EE, al Shunnar A, O'Regan M, et al. Chorionic villous haemorrhage is associated with retroplacental haemorrhage. Br J Obstet Gynaecol. 1994;101:965-969.
58. Rolschau J. Infarctions and intervillous thrombosis in placenta, and their association with intrauterine growth retardation. Acta Obstet Gynecol Scand Suppl. 1978;72:22-27.
59. Bjoro K Jr. Gross pathology of the placenta in intrauterine growth retardation. Ann Chir Gynaecol. 1981;70:316-322.
60. Kos M, Latin V, Hodzic D, et al. Histopathologic findings of placenta and arcuate artery Doppler velociometry in preeclampsia and intrauterine growth retardation. Acta Med Croatica. 1997;51:151-154.
61. Laurini R, Laurin J, Marsal K. Placental histology and fetal blood flow in intrauterine growth retardation. Acta Obstet Gynecol Scand. 1994;73:529-534.
62. Giles WB, Trudinger BJ, Baird PJ. Fetal umbilical artery flow velocity waveforms and placental resistance: pathological correlation. Br J Obstet Gynaecol. 1985;92:31-38.
63. Groome LJ, Owen J, Neely CL, et al. Oligohydramnios: antepartum fetal urine production and intrapartum fetal distress. Am J Obstet Gynecol. 1991;165:1077-1080.
64. Salafia CM, Pezzullo JC, Lopez-Zeno JA, et al. Placental pathologic features of preterm preeclampsia. Am J Obstet Gynecol. 1995;173:1097-1105.
65. Salafia CM, Minior VK, Pezzullo JC, et al. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features. Am J Obstet Gynecol. 1995;173:1049-1057.
66. Salafia CM, Vintzileos AM, Silberman L, et al. Placental pathology of idiopathic intrauterine growth retardation at term. Am J Perinatol. 1992;9:179-184.
67. Salafia CM, Vogel CA, Bantham KF, et al. Preterm delivery: correlations of fetal growth and placental pathology. Am J Perinatol. 1992;9:190-193.
68. Teasdale F. Histomorphometry of the human placenta in pre-eclampsia associated with severe intrauterine growth retardation. Placenta. 1987;8:119-128.
69. Rayburn W, Sander C, Compton A. Histologic examination of the placenta in the growth-retarded fetus. Am J Perinatol. 1989;6:58-61.
70. Biagiotti R, Sgambati E, Brizzi E. Placental morphometry in pregnancies complicated by intrauterine growth retardation with absent or reversed end diastolic flow in the umbilical artery. Ital J Anat Embryol. 1999;104:201-207.
71. Acharya G, Erkinaro T, Makikallio K, et al. Relationships among Doppler-derived umbilical artery absolute velocities, cardiac function, and placental volume blood flow and resistance in fetal sheep. Am J Physiol Heart Circ Physiol. 2004;286:H1266-H1272.
72. Madazli R, Somunkiran A, Calay Z, et al. Histomorphology of the placenta and the placental bed of growth restricted foetuses and correlation with the Doppler velocimetries of the uterine and umbilical arteries. Placenta. 2003;24:510-516.
73. Yagel S, Anteby EY, Shen O, et al. Placental blood flow measured by simultaneous multigate spectral Doppler imaging in pregnancies complicated by placental vascular abnormalities. Ultrasound Obstet Gynecol. 1999;14:262-266.
74. Salafia CM, Pezzullo JC, Minior VK, et al. Placental pathology of absent and reversed end-diastolic flow in growth-restricted fetuses. Obstet Gynecol. 1997;90:830-836.
75. Bruch JF, Sibony O, Benali K, et al. Computerized microscope morphometry of umbilical vessels from pregnancies with intrauterine growth retardation and abnormal umbilical artery Doppler. Hum Pathol. 1997;28:1139-1145.
76. Galan HL, Anthony RV, Rigano S, et al. Fetal hypertension and abnormal Doppler velocimetry in an ovine model of intrauterine growth restriction. Am J Obstet Gynecol. 2005;192:272-279.
77. Trudinger B, Wang J, Athayde N, et al. Association of umbilical placental vascular disease with fetal acute inflammatory cytokine responses. J Soc Gynecol Investig. 2002;9:152-157.
78. Wang X, Athayde N, Trudinger B. Endothelial cell expression of adhesion molecules is induced by fetal plasma from pregnancies with umbilical placental vascular disease. Bjog. 2002;109:770-777.
79. Wang X, Athayde N, Trudinger B. Fetal plasma stimulates endothelial cell production of cytokines and the family of suppressor of cytokine signaling in umbilical placental vascular disease. Am J Obstet Gynecol. 2003;188:510-516.
80. Wang X, Athayde N, Trudinger B. Microvascular endothelial cell activation is present in the umbilical placental microcirculation in fetal placental vascular disease. Am J Obstet Gynecol. 2004;190:596-601.
81. Wang X, Athayde N, Trudinger B. A proinflammatory cytokine response is present in the fetal placental vasculature in placental insufficiency. Am J Obstet Gynecol. 2003;189:1445-1451.
82. Makikallio K, Vuolteenaho O, Jouppila P, et al. Association of severe placental insufficiency and systemic venous pressure rise in the fetus with increased neonatal cardiac troponin T levels. Am J Obstet Gynecol. 2000;183:726-731.
83. Brodszki J, Lanne T, Marsal K, et al. Impaired vascular growth in late adolescence after intrauterine growth restriction. Circulation. 2005;111:2623-2628.
84. Kaukola T, Rasanen J, Herva R, et al. Suboptimal neurodevelopment in very preterm infants is related to fetal cardiovascular compromise in placental insufficiency. Am J Obstet Gynecol. 2005;193:414-420.
85. Fouron JC, Gosselin J, Amiel-Tison C, et al. Correlation between prenatal velocity waveforms in the aortic isthmus and neurodevelopmental outcome between the ages of 2 and 4 years. Am J Obstet Gynecol. 2001;184:630-636.
86. Okahara G, Matsubara S, Oda T, et al. Expression analyses of human endogenous retroviruses (HERVs): tissue-specific and developmental stage-dependent expression of HERVs. Genomics. 2004;84:982-990.
87. Bjoro K, Jr, Myhre E. The role of chronic non-specific inflammatory lesions of the placenta in intra-uterine growth retardation. Acta Pathol Microbiol Immunol Scand [A]. 1984;92:133-137.
88. Althabe O, Labarrere C. Chronic villitis of unknown aetiology and intrauterine growth-retarded infants of normal and low ponderal index. Placenta. 1985;6:369-373.
89. Salafia CM, Silberman L, Herrera NE, et al. Placental pathology at term associated with elevated midtrimester maternal serum alpha-fetoprotein concentration. Am J Obstet Gynecol. 1988;158:1064-1066.
90. Labarrere C, Althabe O, Caletti E, et al. Deficiency of blocking factors in intrauterine growth retardation and its relationship with chronic villitis. Am J Reprod Immunol Microbiol. 1986;10:14-19.
91. Labarrere CA, Althabe OH. Intrauterine growth retardation of unknown etiology: II. Serum complement and circulating immune complexes in maternal sera and their relationship with parity and chronic villitis. Am J Reprod Immunol Microbiol. 1986;12:4-6.
92. Hasegawa I, Takakuwa K, Adachi S, et al. Cytotoxic antibody against trophoblast and lymphocytes present in pregnancy with intrauterine fetal growth retardation and its relation to anti-phospholipid antibody. J Reprod Immunol. 1990;17:127-139.
93. Labarrere C, Althabe O. Chronic villitis of unknown aetiology in recurrent intrauterine fetal growth retardation. Placenta. 1987;8:167-173.
94. Labarrere C, Mullen E. Fibrinoid and trophoblastic necrosis with massive chronic intervillositis: an extreme variant of villitis of unknown etiology. Am J Reprod Immunol Microbiol. 1987;15:85-91.
95. Russell P, Atkinson K, Krishnan L. Recurrent reproductive failure due to severe placental villitis of unknown etiology. J Reprod Med. 1980;24:93-98.
96. Sander CH, Kinnane L, Stevens NG, et al. Haemorrhagic endovasculitis of the placenta: a review with clinical correlation. Placenta. 1986;7:551-574.
97. Redline RW, Pappin A. Fetal thrombotic vasculopathy: the clinical significance of extensive avascular villi. Hum Pathol. 1995;26:80-85.
98. Redline RW, Patterson P. Patterns of placental injury. Correlations with gestational age, placental weight, and clinical diagnoses. Arch Pathol Lab Med. 1994;118:698-701.
99. Nikkels AF, Delbecque K, Pierard GE, et al. Distribution of varicella-zoster virus DNA and gene products in tissues of a first-trimester varicella-infected fetus. J Infect Dis. 2005;191:540-545.
100. Chan G, Stinski MF, Guilbert LJ. Human cytomegalovirus-induced upregulation of intercellular cell adhesion molecule-1 on villous syncytiotrophoblasts. Biol Reprod. 2004;71:797-803.
101. Jordan JA, Huff D, DeLoia JA. Placental cellular immune response in women infected with human parvovirus B19 during pregnancy. Clin Diagn Lab Immunol. 2001;8:288-292.
102. Koi H, Zhang J,Makrigiannakis A, et al. Differential expression of the coxsackievirus and adenovirus receptor regulates adenovirus infection of the placenta. Biol Reprod. 2001;64:1001-1009.
103. Jordan JA, Butchko AR. Apoptotic activity in villous trophoblast cells during B19 infection correlates with clinical outcome: assessment by the caspase-related M30 Cytodeath antibody. Placenta. 2002;23:547-553.
104. Fisher S, Genbacev O, Maidji E, et al. Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol. 2000;74:6808-6820.
105. Winkler M. Role of cytokines and other inflammatory mediators. Bjog. 2003;110(Suppl 20):118-123.
106. Jeffrey IJ. The critical role of perinatal pathology. Bjog. 2003;110(Suppl 20):128-130.
107. Bracci R, Buonocore G. Chorioamnionitis: a risk factor for fetal and neonatal morbidity. Biol Neonate. 2003;83:85-96.
108. Hagberg H, Wennerholm UB, Savman K. Sequelae of chorioamnionitis. Curr Opin Infect Dis. 2002;15:301-306.
109. Edwards RK. Chorioamnionitis and labor. Obstet Gynecol Clin North Am. 2005;32:287-296. x.
110. Redline RW. Placental inflammation. Semin Neonatol. 2004;9:265-274.
111. Garland SM, Ni Chuileannain F, Satzke C, et al. Mechanisms, organisms and markers of infection in pregnancy. J Reprod Immunol. 2002;57:169-183.
112. Salafia CM, Vogel CA, Vintzileos AM, et al. Placental pathologic findings in preterm birth. Am J Obstet Gynecol. 1991;165:934-938.
113. Williams MC, O'Brien WF, Nelson RN, et al. Histologic chorioamnionitis is associated with fetal growth restriction in term and preterm infants. Am J Obstet Gynecol. 2000;183:1094-1099.
114. Blair E, Liu Y, Cosgrove P. Choosing the best estimate of gestational age from routinely collected population-based perinatal data. Paediatr Perinat Epidemiol. 2004;18:270-276.
115. Henriksen TB, Wilcox AJ, Hedegaard M, et al. Bias in studies of preterm and postterm delivery due to ultrasound assessment of gestational age. Epidemiology. 1995;6:533-537.
116. Wang X, Athayde N, Trudinger B. Placental vascular disease and toll-like receptor 4 gene expression. Am J Obstet Gynecol. 2005;192:961-966.
117. Andrews WW, Hauth JC, Goldenberg RL. Infection and preterm birth. Am J Perinatol. 2000;17:357-365.
118. Offenbacher S. Maternal periodontal infections, prematurity, and growth restriction. Clin Obstet Gynecol. 2004;47:808-821. Discussion 881-802.
119. Naldini A, Carraro F. Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy. 2005;4:3-8.